Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Stealth Biotherapeutics Corp Ads (MITO)

Stealth Biotherapeutics Corp Ads (MITO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 72,862
  • Shares Outstanding, K 35,030
  • Annual Sales, $ 21,090 K
  • Annual Income, $ -71,730 K
  • 60-Month Beta 2.89
  • Price/Sales 3.49
  • Price/Cash Flow N/A
  • Price/Book 30.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.02
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.76 +14.96%
on 07/17/20
2.50 -19.06%
on 08/03/20
+0.20 (+11.02%)
since 07/02/20
3-Month
1.59 +27.26%
on 05/06/20
2.50 -19.06%
on 08/03/20
+0.43 (+26.96%)
since 05/05/20
52-Week
0.90 +124.77%
on 03/18/20
14.41 -85.96%
on 12/18/19
-10.10 (-83.31%)
since 08/05/19

Most Recent Stories

More News
Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 2.00 (-3.85%)
Stealth BioTherapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 2.00 (-3.85%)
Stealth BioTherapeutics to Present at Jefferies Virtual Healthcare Conference

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 2.00 (-3.85%)
Stealth BioTherapeutics Corp (MITO) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Stealth BioTherapeutics Corp (MITO).

MITO : 2.00 (-3.85%)
Stealth BioTherapeutics to Present at UBS Virtual Global Healthcare Conference

, /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 2.00 (-3.85%)
Stealth BioTherapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights

, /PRNewswire/ --  Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction,...

MITO : 2.00 (-3.85%)
Stealth BioTherapeutics to Report First Quarter 2020 Financial Results on Thursday, May 7, 2020

, /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving...

MITO : 2.00 (-3.85%)
Stealth BioTherapeutics Corp (MITO) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Stealth BioTherapeutics Corp (MITO).

MITO : 2.00 (-3.85%)
Global Market for Cancer Therapies Could Exceed US$220 Billion by 2025

Despite decades of research costing billions of dollars, a cure for cancer still remains elusive. This fact when juxtaposed with the epidemic spread of cancer will result in the disease emerging into the...

SPEX : 1.6300 (-18.09%)
INO : 21.80 (+7.28%)
MITO : 2.00 (-3.85%)
PFE : 38.41 (+0.05%)
LLY : 154.40 (-0.29%)
OMER : 13.80 (+5.42%)
4 Reasons Why Investors Should Buy Alexion (ALXN) in 2020

Alexion's (ALXN) growth prospects look strong for 2020 as Soliris maintains momentum and Ultomiris gains further traction.

ACHN : 6.76 (+10.28%)
ALXN : 102.68 (-2.41%)
AMGN : 241.55 (-0.84%)
MITO : 2.00 (-3.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade MITO with:

Business Summary

Stealth BioTherapeutics Corp is a biopharmaceutical company. It is engaged in developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases. The company's product pipeline includes Elamipretide, SBT-20 and SBT-272 which...

See More

Key Turning Points

2nd Resistance Point 2.31
1st Resistance Point 2.19
Last Price 2.00
1st Support Level 1.99
2nd Support Level 1.91

See More

52-Week High 14.41
Fibonacci 61.8% 9.25
Fibonacci 50% 7.66
Fibonacci 38.2% 6.06
Last Price 2.00
52-Week Low 0.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar